Pacira BioSciences, Inc.
PCRX
$27.00
-$0.14-0.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -99.56M | -90.73M | 63.59M | 70.47M | 41.96M |
| Total Depreciation and Amortization | 78.79M | 76.03M | 74.21M | 74.40M | 75.57M |
| Total Amortization of Deferred Charges | 3.22M | 3.06M | 2.91M | 2.84M | 3.75M |
| Total Other Non-Cash Items | 225.46M | 225.32M | 73.77M | 58.86M | 79.15M |
| Change in Net Operating Assets | -18.52M | -9.83M | -20.12M | -21.95M | -45.78M |
| Cash from Operations | 189.39M | 203.84M | 194.36M | 184.62M | 154.65M |
| Capital Expenditure | -10.64M | -10.32M | -9.62M | -11.43M | -15.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.64M | -64.22M | -17.10M | 7.26M | 92.70M |
| Cash from Investing | -83.28M | -74.53M | -26.71M | -4.17M | 77.54M |
| Total Debt Issued | 287.50M | 287.50M | 287.50M | 0.00 | 149.55M |
| Total Debt Repaid | -210.89M | -210.89M | -235.88M | -36.25M | -330.31M |
| Issuance of Common Stock | 2.30M | 2.50M | 2.53M | 4.42M | 4.75M |
| Repurchase of Common Stock | -25.49M | -25.52M | -25.49M | -110.00K | -106.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -36.06M | -36.06M | -36.06M | 0.00 | -6.91M |
| Cash from Financing | 17.36M | 17.54M | -7.40M | -31.94M | -183.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.48M | 146.85M | 160.24M | 148.51M | 49.16M |